Trials / Conditions / Von Hippel Lindau
Von Hippel Lindau
5 registered clinical trials studyying Von Hippel Lindau — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342 | Reveal Pharmaceuticals Inc. | Phase 2 |
| Recruiting | Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial NCT07167329 | José Claudio Casali da Rocha | Phase 2 |
| Terminated | 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors NCT05563272 | Telix Pharmaceuticals (Innovations) Pty Ltd | Phase 2 |
| Completed | Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau NCT03907657 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Completed | Phase II Study of Vandetanib in Individuals With Kidney Cancer NCT00566995 | National Cancer Institute (NCI) | Phase 2 |